secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicus Pharma Ltd. (MDCX)
CIK:        0001997296
Form:       8-K
Filed at:   2026-05-27T20:45:00+00:00
Accession:  0001062993-26-002900
Event type: debt
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 2.03, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medicus Pharma closes $22M secured notes with Streeterville; receives Nasdaq MVLS non-compliance notice
--------------------------------------------------------------------------------

- Issued two secured promissory notes to Streeterville Capital: A-1 ($12.86M principal, net $12M) and B ($10M in DACA), maturing in 18 months.
- A-1 Note carries 8.75% interest and $834K OID; B Note 5% interest. Prepayment premiums of 110-115% apply.
- Proceeds support clinical development, strategic initiatives, and repayment of $2.5M YA II PN debenture.
- Nasdaq notified non-compliance with $35M MVLS requirement; company has 180 days to regain compliance by Nov 16, 2026.
- B Note can be exchanged for A Notes when A principal reduced by $2M; trigger events allow balance increases of 15%/5%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-26-002900

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer